Usefulness of cortisol/ACTH ratio (CAR) for diagnosis of cushing's syndrome: comparison of CAR with findings in dexamethasone suppression test

被引:0
作者
Yuichiro Iwamoto
Fuminori Tatsumi
Takashi Itoh
Taku Sasaki
Shigehito Mori
Toshitomo Sugisaki
Erina Nakao
Mana Ohnishi
Takashi Kusano
Haruka Takenouchi
Hideyuki Iwamoto
Junpei Sanada
Yoshiro Fushimi
Yukino Katakura
Tomohiko Kimura
Masashi Shimoda
Shuhei Nakanishi
Kohei Kaku
Tomoatsu Mune
Hideaki Kaneto
机构
[1] Kawasaki Medical School,Department of Diabetes, Endocrinology and Metabolism
来源
Scientific Reports | / 12卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Cushing's syndrome and subclinical Cushing's syndrome (SCS) are conditions of increased cortisol secretion from the adrenal glands. Cushing's syndrome includes adrenocorticotropic hormone (ACTH)-dependent Cushing's syndrome (Cushing's disease) and ACTH-independent Cushing's syndrome (AICS). The purpose of this study was to investigate the diagnostic potential of the cortisol / adrenocorticotropic hormone (ACTH) ratio (CAR) for diagnosis of Cushing's syndrome or SCS in adult subjects. This was a single-center, retrospective, observational study. This study enrolled 44 subjects with SCS, 14 AICS, 10 CD, and 248 non-Cushing's syndrome subjects who had undergone a 1 mg dexamethasone suppression test (1 mg DST). Definition of SCS was as follows: no physical signs characteristic of Cushing syndrome and cortisol was ≥ 83 nmol/L in 1 mg DST. The diagnostic potential of CAR for diagnosis of Cushing's syndrome was evaluated by comparing the correlation between CAR and after-load cortisol level in 1 mg DST. As the results, there was a strong positive correlation between CAR and after-load cortisol level in subjects with AICS (r = 0.800, p < 0.005). CAR was 10,040 ± 4170 nmol/pmol in subjects with NCS, 17,535 ± 10,246 nmol/pmol in SCS, 101,221 ± 18,009 nmol/pmol in AICS, and 4324 ± 2051 nmol/pmol in CD, all of which were significantly higher compared to those with AICS (p < 0.0005). The cutoff values of CAR for screening at our institution were 11,849.6 nmol/pmol for AICS (AUC 0.935, p < 0.005, sensitivity 92.3%, specificity 83.5%) and 7006.1 nmol/pmol for CD (AUC 0.714, p < 0.05, sensitivity 100.0%, specificity 46.8%). There was a positive correlation between CAR and adrenal adenoma diameter in subjects with AICS (r = 0.508, p < 0.05), but there was no correlation between tumor diameter and CAR in subjects with SCS and CD. In conclusion, high CAR indicates increased cortisol secretion from the adrenal glands. Since CAR is a simple indicator that can be easily evaluated by general practitioners as well as endocrinologists, we think CAR would be useful for the early detection of Cushing's syndrome.
引用
收藏
相关论文
共 21 条
[1]  
Newell-Price J(1998)The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states Endocr. Rev. 19 647-672
[2]  
Reincke M(2000)Subclinical Cushing's syndrome Endocrinol. Metab. Clin. North Am. 29 43-56
[3]  
Nieman LK(2019)Hypertension and cardiovascular mortality in patients with Cushing syndrome Endocrinol. Metab. Clin. North Am. 48 717-725
[4]  
Mazziotti G(2011)Diabetes in Cushing syndrome: Basic and clinical aspects Trends Endocrinol. Metab. 22 499-506
[5]  
Gazzaruso C(2014)Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: A 15-year retrospective study Lancet. Diabetes Endocrinol. 2 396-405
[6]  
Giustina A(2016)Cushing's syndrome: Screening and diagnosis High Blood Press Cardiovasc. Prev. 23 209-215
[7]  
Di Dalmazi G(2016)Management of adrenal incidentalomas: European society of endocrinology clinical practice guideline in collaboration with the European network for the study of adrenal Tumors Eur. J. Endocrinol. 175 G1-g34
[8]  
Ceccato F(2021)Association between mortality and levels of autonomous cortisol secretion by adrenal incidentalomas: A cohort study Ann. Intern. Med. 174 1041-1049
[9]  
Boscaro M(2019)Primary aldosteronism diagnosis and management: A clinical approach Endocrinol. Metab. Clin. North. Am. 48 681-700
[10]  
Fassnacht M(2016)The management of primary aldosteronism: case detection, diagnosis, and treatment: An endocrine society clinical practice guideline J. Clin. Endocrinol. Metab. 101 1889-1916